Bong Min Ko

Bong Min Ko


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2021 in Intestinal Research
Verified
Journal Article
Open access
PDF file
YJYujin Jeong
Yujin Jeong
Seong Ran JeonSeong Ran Jeon
Seong Ran Jeon
HKHyun Gun Kim
Hyun Gun Kim
JMJung Rock Moon
Jung Rock Moon
TLTae Hee Lee
Tae Hee Lee
SPSuyeon Park
Suyeon Park
Background/Aims: Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) can serve as biomarkers for diagnosing and assessing disease activity in ulcerative colitis (UC). We investigated their clinical significance in UC.Methods: We analyzed 48 patients with UC who underwent measurement of fecal calprotectin (FC) and endoscopy and 96 age- and sex-matched healthy controls. NLR and PLR were compared between the patients and healthy controls. The endoscopic activity was divided into 2 groups: group 1 (mild to moderate inflammation) and group 2 (severe inflammation) according to the Mayo endoscopic subscore in UC.Results: To diagnose UC, the optimal cutoff of NLR and PLR was 2.26 (sensitivity 54.2%; specificity 90.6%; positive likelihood ratio 5.778, 95% confidence interval [CI] 2.944–11.339; area under the curve [AUC] 0.774, 95% CI, 0.690–0.859) and 179.8 (sensitivity 35.4%; specificity 90.6%; positive likelihood ratio 3.778, 95% CI 1.821–7.838; AUC 0.654, 95% CI 0.556–0.753), respectively. The optimal cutoff to differentiate group 1 and group 2 was 3.44, 175.9, and 453 µg/g for NLR, PLR, and FC, respectively (sensitivity, 63.6% vs. 90.9% vs. 81.8%; specificity, 81.1% vs. 78.4% vs. 73.0%; positive likelihood ratio, 3.364 vs. 4.205 vs. 3.027; AUC, 0.714 vs. 0.897 vs. 0.813). PLR had the highest AUC and positive likelihood ratio.Conclusions: NLR and PLR help differentiate patients with UC from healthy controls. NLR, PLR, and FC indicate endoscopic activity and may reflect intestinal mucosal conditions.

1 January 2014 in Intestinal Research
Verified
Journal Article
Open access
PDF file
YCYoun Hee Cho
Youn Hee Cho
BKBong Min Ko
Bong Min Ko
SKShin Hee Kim
Shin Hee Kim
YMYu Sik Myung
Yu Sik Myung
JCJong Hyo Choi
Jong Hyo Choi
MLMoon Sung Lee
Moon Sung Lee
Cho YH, et al. Intest Res. 2014 Apr;12(2):139-145. https://doi.org/10.5217/ir.2014.12.2.139

13 September 2022 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
JSJongbeom Shin
Jongbeom Shin
EKEun Ran Kim
Eun Ran Kim
HJHyun Joo Jang
Hyun Joo Jang
DBDong Hoon Baek
Dong Hoon Baek
DYDong-Hoon Yang
Dong-Hoon Yang
SJSeong Woo Jeon
Seong Woo Jeon
Background: Endoscopic submucosal dissection (ESD) can provide a high en bloc resection rate and has been widely applied as curative treatment for early colorectal cancer (ECC). However, surgical treatment is occasionally required, and reports on the long-term prognosis of ESD are insufficient. This study aimed to investigate the long-term outcomes of ECC removal by ESD, including local recurrence and metastasis. Methods: This multicenter study was conducted retrospectively on 450 consecutive patients with ECC who were treated with ESD between November 2003 and December 2013. Clinical, pathological, and endoscopic data were collected to determine tumor depth, resection margin, lymphovascular invasion, and recurrence. Results: The median follow-up period was 53.8 (12–138 months). The en bloc resection rate was 85.3% (384) and in intramucosal cancer being 84.1% and in superficial submucosal invasion (SM1) cancer being 89.8% (p = 0.158). The curative resection rate was 76.0% (n = 342), and there was no statistical difference between the two groups (77.3% vs. 71.4%, p = 0.231). The overall recurrence free survival rate (RFS) was 98.7% (444/450). In patients with curative resection, there was no statistically significant difference in RFS according to invasion depth (intramucosal: 99.3% vs. SM1: 97.1%, p = 0.248). Conclusions: Patients with curatively resected ECC treated with ESD showed favorable long-term outcomes. Curatively resected SM1 cancer has a RFS similar to that of intramucosal cancer.

31 May 2017 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
BKBong Min Ko
Bong Min Ko
Endoscopic submucosal dissection (ESD) procedure is composed of circumferential mucosal incision and submucosal dissection. A variety of endoscopic accessories are required to perform mucosal incision and submucosal dissection safely. As a result of the improvements in ESD devices and peripheral equipment and development of the ESD technique, ESD procedures have been performed extensively worldwide. Here I review the history of the development of accessories used in performing ESD procedures.

11 April 2019 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
HKHaewon Kim
Haewon Kim
BKBong Min Ko
Bong Min Ko
HGHyeon Jeong Goong
Hyeon Jeong Goong
YJYun Ho Jung
Yun Ho Jung
SJSeong Ran Jeon
Seong Ran Jeon
MLMoon Sung Lee
Moon Sung Lee

1 January 2016 in The Korean Journal of Gastroenterology
Verified
Journal Article
Open access
PDF file
HNHyung Min Noh
Hyung Min Noh
SHSu Jin Hong
Su Jin Hong
JHJae Pil Han
Jae Pil Han
KPKyung Woo Park
Kyung Woo Park
YLYun Nah Lee
Yun Nah Lee
MLMoon Sung Lee
Moon Sung Lee
Noh HM, et al. Korean J Gastroenterol. 2016 Nov;68(5):260-264. https://doi.org/10.4166/kjg.2016.68.5.260